The BMJ reports that the person leading the UK government's national programme for trialling new obesity treatments has received nearly £80, with the full figure behind the link.
Recap by typeshit. Post by The BMJ on X.
Beauty companies are reportedly exploring products aimed at facial volume loss in people who have lost weight on GLP-1 drugs.
A short Fox16 social clip points to GLP-1 users shifting how they drink when they go out, with the full story linked in the station's bio.
A Facebook share points to shifting drinking habits in pubs and bars as more people take GLP-1 medications, with the full story linked.
Food Dive reports the Atkins brand is shifting its pitch toward lapsed GLP-1 users, a growing group food companies are now chasing.
Lilly says the 12 mg dose cut weight 21% versus 9% on Ozempic over 80 weeks, though 8% quit over side effects compared with 3% on Novo's drug.
AP reports agency scientists did not back the administration's effort to loosen rules on peptide drugs that remain unproven.
Loading…